NeoMed makes first life science fund close

NeoMed Management, a Norway-based life sciences venture capital firm, has completed the first closing for its fourth fund at €38m ($50.3m).

The final fundraising target is €100m, which the firm expects to achieve by the summer.

WSJ Logo
Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a BillionaireExternal link

Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a Billionaire